scholarly journals Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: A report from the National Cardiovascular Data Registry

2013 ◽  
Vol 83 (2) ◽  
pp. 171-181 ◽  
Author(s):  
Michael A. Kutcher ◽  
J. Matthew Brennan ◽  
Sunil V. Rao ◽  
David Dai ◽  
Kevin J. Anstrom ◽  
...  
Keyword(s):  
Elderly Patients ◽  
Comparative Effectiveness ◽  
Drug Eluting Stents ◽  
Long Term Outcomes ◽  
Stent Restenosis ◽  
Data Registry ◽  
Drug Eluting ◽  
National Cardiovascular ◽  
In Stent Restenosis

Vascular brachytherapy versus drug-eluting stents in the treatment of in-stent restenosis: A meta-analysis of long-term outcomes

2015 ◽  
Vol 87 (2) ◽  
pp. 200-208 ◽  
Author(s):  
Alexandre Benjo ◽  
Rhanderson N. Cardoso ◽  
Tyrone Collins ◽  
Daniel Garcia ◽  
Francisco Y. Macedo ◽  
...  
Keyword(s):  
Meta Analysis ◽  
Drug Eluting Stents ◽  
Long Term Outcomes ◽  
Stent Restenosis ◽  
Vascular Brachytherapy ◽  
Drug Eluting ◽  
In Stent Restenosis

scholarly journals Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice

2011 ◽  
Vol 6 (6) ◽  
pp. 748-753 ◽  
Author(s):  
Clare Appleby ◽  
Raj Khattar ◽  
Kenneth Morgan ◽  
Bernard Clarke ◽  
Nicholas Curzen ◽  
...  
Keyword(s):  
Real World ◽  
Drug Eluting Stents ◽  
Bare Metal ◽  
Long Term Outcomes ◽  
Stent Restenosis ◽  
Drug Eluting ◽  
In Stent Restenosis

scholarly journals TCT-661 Vascular Brachytherapy versus Drug-Eluting Stents in the Treatment of In-Stent Restenosis: a Meta-Analysis of Long Term Outcomes

2014 ◽  
Vol 64 (11) ◽  
pp. B192-B193
Author(s):  
Rhanderson N. Cardoso ◽  
Alexandre M. Benjo ◽  
Tyrone Collins ◽  
Daniel Garcia ◽  
Francisco Y. Macedo ◽  
...  
Keyword(s):  
Meta Analysis ◽  
Drug Eluting Stents ◽  
Long Term Outcomes ◽  
Stent Restenosis ◽  
Vascular Brachytherapy ◽  
Drug Eluting ◽  
In Stent Restenosis

Femtosecond Laser Nanotexturing of Drug-Eluting Stents

2012 ◽  
Vol 134 (6) ◽  
Author(s):  
Rajeev Nair ◽  
Vaelan Molian ◽  
Pal Molian
Keyword(s):  
Femtosecond Laser ◽  
Cost Effective ◽  
Interventional Cardiology ◽  
Drug Eluting Stents ◽  
Potential Cost ◽  
Polymer Carrier ◽  
Stent Restenosis ◽  
Drug Eluting ◽  
In Stent Restenosis

Drug-eluting stents (DES) have profoundly affected the field of interventional cardiology by dramatically reducing the problem of in-stent restenosis. However, the adverse, long-term, thrombosis raises the questions on the safety profile of DES. Femtosecond pulsed laser nanotexturing of metallic stents was performed to minimize thrombosis by improving three fundamental characteristics of DES: (1) increase the availability of drug for elution; (2) enhance the adhesion between stent and drug; and (3) minimize and, if possible, eliminate the polymer carrier. Results of laser-induced nanoprotrusion/drug interactions confirmed these benefits and indicated that femtosecond laser nanotexturing is a potential cost-effective solution for improving the performance and safety of DES while eliminating the need for postfinishing operations.

Long Term Clinical Outcomes of Treatment of In-Stent Restenosis With Drug Eluting Stents

2009 ◽  
Vol 18 ◽  
pp. S5
Author(s):  
S Cherian ◽  
C Sebastian ◽  
A Puri ◽  
M Liang ◽  
G Devlin
Keyword(s):  
Clinical Outcomes ◽  
Drug Eluting Stents ◽  
Stent Restenosis ◽  
Drug Eluting ◽  
In Stent Restenosis

Treatment of In-stent Restenosis – Past, Present and Future

2009 ◽  
Vol 5 (2) ◽  
pp. 74 ◽  
Author(s):  
Fernando Alfonso ◽  
Keyword(s):  
Clinical Problem ◽  
Historical Background ◽  
Drug Eluting Stents ◽  
Bare Metal ◽  
Future Perspectives ◽  
Technical Challenge ◽  
Stent Restenosis ◽  
Drug Eluting ◽  
In Stent Restenosis

In-stent restenosis (ISR) remains a significant clinical problem. The penetration of drug-eluting stents (DES) is quite variable and patients with DES may also suffer from ISR. Treatment of ISR remains a technical challenge and the long-term clinical outcome of these patients may be complicated by recurrences. Different strategies have been used for the treatment of patients with bare-metal ISR. Currently, DES constitute the intervention of choice in this setting. However, the best intervention for patients suffering from ISR after DES implantation remains to be elucidated. This report summarises our clinical and research efforts in this adverse anatomical scenario over the last decade. We will address the treatment of patients with ISR, revisiting the historical background, emphasising the currently available alternatives and disclosing future perspectives.

Sign in / Sign up

Export Citation Format

Share Document